Details of the Drug

General Information of Drug (ID: DM39AME)

Drug Name

LP-261

Synonyms

LP-261; 915412-67-8; UNII-O547O19Z01; O547O19Z01; SCHEMBL3933505; ZINC34602681; SB19852; KB-78192; Z-3261; N-(3-(1h-indol-4-yl)-5-(2 methoxyisonicotinoyl)phenyl)methanesulfonamide

Indication

Disease Entry	ICD 11	Status	REF
Solid tumour/cancer	2A00-2F9Z	Phase 1	[1]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Structure

3D MOL

2D MOL

Chemical Identifiers

Formula: C22H19N3O4S
Canonical SMILES: COC1=NC=CC(=C1)C(=O)C2=CC(=CC(=C2)C3=C4C=CNC4=CC=C3)NS(=O)(=O)C
InChI: 1S/C22H19N3O4S/c1-29-21-13-14(6-8-24-21)22(26)16-10-15(11-17(12-16)25-30(2,27)28)18-4-3-5-20-19(18)7-9-23-20/h3-13,23,25H,1-2H3
InChIKey: YUVDELGTFILMBB-UHFFFAOYSA-N

Cross-matching ID

PubChem CID: 15603282
CAS Number: 915412-67-8
TTD ID: D00KVX

References

1	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800020661)